The Electric and Magnetic Field Instrument and Integrated Science (EMFISIS) investigation on the NASA Radiation Belt Storm Probes (now named the Van Allen Probes) mission provides key wave and very low frequency magnetic field measurements to understand radiation belt acceleration, loss, and transport. The key science objectives and the contribution that EMFISIS makes to providing measurements as well as theory and modeling are described. The key components of the instruments suite, both electronics and sensors, including key functional parameters, calibration, and performance, demonstrate that EMFI-SIS provides the needed measurements for the science of the RBSP mission. The EMFISIS operational modes and data products, along with online availability and data tools provide the radiation belt science community with one the most complete sets of data ever collected.
Abstract. The Plasma Wave Instrument on the Polar spacecraft is designed to provide measurements of plasma waves in the Earth's polar regions over the frequency range from 0.l Hz to 800 kHz. Three orthogonal electric dipole antennas are used to detect electric fields, two in the spin plane and one aligned along the spacecraft spin axis. A magnetic loop antenna and a triaxial magnetic search coil antenna are used to detect magnetic fields. Signals from these antennas are processed by five receiver systems: a wideband receiver, a high-frequency waveform receiver, a low-frequency waveform receiver, two multichannel analyzers; and a pair of sweep frequency receivers. Compared to previous plasma wave instruments, the Polar plasma wave instrument has several new capabilities. These include (1) an expanded frequency range to improve coverage of both low-and high-frequency wave phenomena, (2) the ability to simultaneously capture signals from six orthogonal electric and magnetic field sensors, and (3) a digital wideband receiver with up to 8-bit resolution and sample rates as high as 249k samples s -_ .
BackgroundThe delay in discharge or transfer of care back to the community following an acute admission to the hospital in older adults has long been a recognized challenge in the UK. We examined the determinants and outcomes of delayed transfer of care in older adults.MethodsA prospective observational study was conducted in a district general hospital with a catchment population of 250,000 in England, UK. Those >= 65 years admitted to two care of the elderly wards during February 2007 were identified and prospectively followed-up till their discharge. Data was presented descriptively.Results36.7% (58/158) of patients had a delay in transfer of care. They tended to be older, had poorer pre-morbid mobility, and were more likely to be confused at the time of admission. Compared to the 2003 National Audit Report, a significantly higher percentage (29.3%vs.17%) awaited therapist assessments or (27.6%vs.9%) domiciliary care, with a lower percentage (< 1%vs.14%) awaiting further NHS care. Of 18 in-patient deaths, five occurred during the delay. Seven patients developed medical conditions during the delay making them unfit for discharge. The number of extra bed days attributable to delayed discharges in this study was 682 (mean = 4.8) days.ConclusionAwaiting therapy and domiciliary care input were significant contributing factors in delayed transfer of care. Similar local assessments could provide valuable information in identifying areas for improvement. Based on available current evidence, efficacy driven changes to the organisation and provision of support, for example rapid response delayed discharge services at the time of "fit to discharge" may help to improve the situation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.